Celestica (CLS) director Jill Kale receives 190 D‑RSUs in equity grant

Rhea-AI Filing Summary

Kale Jill reported acquisition or exercise transactions in this Form 4 filing.

CELESTICA INC director Jill Kale received an equity-based compensation grant of 190 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU represents a contingent right to receive one common share or, at the company’s election, an equivalent cash amount. Following this award, Kale holds 1,000 D‑RSUs, which vest on May 20, 2027, subject to her deferral election.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kale Jill

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Restricted Share Units F1, F2	190	$0.00	$0.00

Holdings After Transaction: Director Restricted Share Units — 1,000 shares (Direct)

Footnotes (2)

1. F1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
2. F2. On August 11, 2026, the reporting person was granted 190 D-RSUs, which vest on May 20, 2027.

Key Figures

D‑RSUs granted: 190 Director Restricted Share Units Total D‑RSUs after grant: 1,000 Director Restricted Share Units Vesting date: May 20, 2027 +1 more

4 metrics

D‑RSUs granted 190 Director Restricted Share Units Grant to director Jill Kale on August 11, 2026

Total D‑RSUs after grant 1,000 Director Restricted Share Units Direct holdings following the reported transaction

Vesting date May 20, 2027 Vesting date for the 190 D‑RSUs granted August 11, 2026

Conversion ratio 1 D‑RSU : 1 common share Each D‑RSU represents a contingent right to receive one common share

Key Terms

Director Restricted Share Units, D-RSU, contingent right, deferral election

4 terms

Director Restricted Share Units financial

"Each director restricted share unit ("D-RSU") represents a contingent right"

D-RSU financial

"On August 11, 2026, the reporting person was granted 190 D-RSUs"

contingent right financial

"represents a contingent right to receive one common share upon settlement"

deferral election financial

"upon settlement, subject to the reporting person's deferral election"

FAQ

What did Celestica (CLS) director Jill Kale report in this Form 4?

Kale reported a grant of 190 Director Restricted Share Units (D‑RSUs) on August 11, 2026. These units are equity-based compensation that convert into common shares or cash at settlement, subject to plan terms.

How many Celestica (CLS) D‑RSUs does Jill Kale hold after this transaction?

After the reported grant, Jill Kale holds a total of 1,000 Director Restricted Share Units. This figure reflects her direct derivative holdings reported as of the Form 4’s transaction date.

When do Jill Kale’s newly granted Celestica (CLS) D‑RSUs vest?

The 190 D‑RSUs vest on May 20, 2027. Vesting must occur before settlement into common shares or equivalent cash, consistent with the director compensation plan’s terms.

What does each Celestica (CLS) Director Restricted Share Unit represent?

Each D‑RSU represents a contingent right to receive one common share upon settlement or, at Celestica’s election, an equivalent cash value, subject to the director’s deferral election.

Is this Celestica (CLS) Form 4 a market buy or sell by Jill Kale?

No. The Form 4 reports a grant/award acquisition of 190 D‑RSUs as director compensation. It does not reflect an open-market purchase or sale of Celestica common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 04:47 PM Accepted by SEC EDGAR 08/12/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kale Jill

(Last) (First) (Middle)

5140 YONGE STREET

SUITE 1900

(Street)

TORONTO M2N 6L7

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Restricted Share Units	(1)	08/11/2026		A		190		(2)	(2)	Common Shares	190	$0	1,000	D

Explanation of Responses:

1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.

2. On August 11, 2026, the reporting person was granted 190 D-RSUs, which vest on May 20, 2027.

	/s/ Tracy Connelly McGilley, attorney-in-fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)